Nikolaus B. Wagner

S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies

Nikolaus B. Wagner, Andrea Forschner, Ulrike Leiter et al. · British Journal of Cancer · 2018 · 125 citations · Full text

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Nikolaus B. Wagner, Benjamin Weide, Mirko Gries et al. · Journal for ImmunoTherapy of Cancer · 2019 · 107 citations · Full text

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas

Maximilian Gassenmaier, Matthias Hahn, Gisela Metzler et al. · Cancers · 2021 · 45 citations · Full text

Diminished levels of the soluble form of <scp>RAGE</scp> are related to poor survival in malignant melanoma

Nikolaus B. Wagner, Benjamin Weide, Maike Reith et al. · International Journal of Cancer · 2015 · 33 citations · Full text

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

Jonas Bochem, Henning Zelba, Teresa Amaral et al. · PLoS ONE · 2019 · 20 citations · Full text

Pd-1 Blockade, Immunology, Pathology +17